Solimar acquired by Vivalto Vie

SPAIN Health Providers / Healthcare Facilities / Nursing Homes EV €20–50M

Context

Vivalto Vie acquired 100% of Solimar, a Valencia-based nursing home operator, marking the group's first international expansion outside France. The transaction was executed simultaneously with the closing of the Amundi PEF-led LBO of Vivalto Vie and represents the first building block of the group's Spanish platform, which targets a pipeline of approximately 1,000 additional beds through a combination of further acquisitions and greenfield development projects.

Solimar, which reported an EBITDA margin of [members only] in 2018, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x in 2026).

-> Deep-dive in Healthcare & Pharma market trends

Target

Solimar is a Spanish nursing home operator based in the Valencia region, operating seven residential care establishments with approximately 930 beds. The group provides residential care services to elderly and dependent people in one of Spain's most populous regions. Solimar represents a well-established local operator in a highly fragmented Spanish nursing home market, which is characterised by strong structural growth dynamics driven by an ageing population and a development stage approximately ten years behind the French market in terms of private sector consolidation.

Ent. Value

€20–50M

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2018

2017

Other operations with Vivalto Vie

Other operations with Vivalto Vie
Date	Acquirer	Target	Country	Sector
02/2020	AMUNDI PRIVATE EQUITY / SOCIETE GENERALE CAPITAL PARTENAIRES	VIVALTO VIE	FRANCE	Nursing Homes

Similar deals in Health Providers

Similar deals in Health Providers
Date	Acquirer	Target	Country	Sector
06/2020	ASKLEPIOS KLINIKEN	RHÖN-KLINIKUM	GERMANY	Clinics / Hospitals
03/2020	ORPEA	TLC GROUP	IRELAND	Nursing Homes
02/2020	AMUNDI PRIVATE EQUITY / SOCIETE GENERALE CAPITAL PARTENAIRES	VIVALTO VIE	FRANCE	Nursing Homes
02/2020	CLARIANE	INICEA	FRANCE	Clinics / Hospitals
01/2020	VIVALTO SANTÉ	MATHILDE MÉDICAL DÉVELOPPEMENT	FRANCE	Clinics / Hospitals
01/2020	ARDIAN	SANTE CIE	FRANCE	Health Providers
12/2019	CIRCLE HEALTH	BMI HEALTHCARE	UNITED KINGDOM	Clinics / Hospitals
07/2019	NAXICAP PARTNERS / ARDIAN	EMERA	FRANCE	Nursing Homes
07/2019	I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENT	DOMIDEP	FRANCE	Nursing Homes
07/2019	TRITON PARTNERS	ALERIS	SWEDEN	Clinics / Hospitals

REFERENCES

Valuation range: EV €20–50M

Revenue range: €5–25M

EV/Revenue range: 2x - 6x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Solimar by Vivalto Vie are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers Vivalto Vie’s acquisition of 100% of Solimar, a Spanish company specialised in Healthcare Facilities, in 2020.

How was the acquisition of Solimar by Vivalto Vie valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €20–50M band and its EV/revenue multiple within the 2x - 6x range. Exact figures are available to members.

What was Solimar’s revenue at the time of the deal?

At the time of the transaction, Solimar’s annual revenue was estimated within the €5–25M range (FY 2018). Detailed financial figures are available to members.

How does the valuation of Solimar compare to benchmarks in the Healthcare & Pharma sector?

Transaction multiples for this specific deal are exclusively reserved for mynth members. By way of comparison, in 2026 companies in the Healthcare & Pharma sector are valued at a multiple of 14.3x EBITDA.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.